| 1/222 | US=61 / Tese/FAP Begnami MDFS. Estudo da frequência de infecção pelo virus de Epstein-Barr em adeno carcinomas gástricos, sua relação com o ciclo celular e sintases do óxido nítrico. São Paulo, 2002. 70 p. Dissertação(Mestrado)-Fundação Antonio Prudente. Disponível em: http://accamargo.phlnet.com.br/MESTRADO/2003/us61.pdf VIRUS EPSTEIN-BARR; CANCER GASTRICO; CICLO CELULAR; APOPTOSE; OXIDO NITRICO; PROTEINA P53 |
| 2/222 | US=9 / Câncer Borthakur G, Bueso-Ramos CE, O'Brien S. Chronic lymphocytic leukemia and associated disorders. In: Kantarjian HM. The MD Anderson manual of medical oncology. New York: McGraw-Hill, 2006. p. 39-55. EPIDEMIOLOGIA; BIOLOGIA; ORIGEM CELULAR; CITOGENETICA; RESISTENCIA A APOPTOSIS; DIAGNOSTICO; DIAGNOSTICO DIFERENCIAL; ESTAGIO; PROGNOSTICO; AGENTES ALQUILANTES; ANTICORPOS MONOCLONAIS; TRANSPLANTE DE CELULAS TRONCO; SINDROME RICHTER'S; TRANSFORMACAO PROLINFOCITICA; LEUCEMIA DE CELULAS PILOSAS; LEUCEMIA PROLINFOCITICA |
| 3/222 | US=22 / Câncer Song Y, Samulski TD, Van Dyke TA. Cancer: a conceptual framework. In: Devita Jr VT, Hellman S, Rosenberg AS. DeVita, Hellman, and Rosenberg’s cancer: principles & practice of oncology. 8ªed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 3-12. HISTORICO; BASES MOLECULAR DO CANCER; MECANISMOS DO CANCER; GENES DO CANCER; APOPTOSIS; ANGIOGENESIS; METASTASES INVASIVAS |
| 4/222 | US=22 / Câncer Karantza-Wadsworth V, White EP. Programmed cell death. In: Devita Jr VT, Hellman S, Rosenberg AS. DeVita, Hellman, and Rosenberg’s cancer: principles & practice of oncology. 8ªed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 93-101. CONTROLE DE APOPTOSIS; AUTOFAGIA; CONDUTAS ALTERNATIVAS; MORTE CELULAR; PAPEL DA AUTOFAGIA EM SUPRESSAO DO TUMOR; INDUCAO TERAPEUTICA; NECROTICA/MORTE CELULAR |
| 5/222 | US=22 / Câncer Minn AJ, Massagué J. Invasion and metastasis. In: Devita Jr VT, Hellman S, Rosenberg AS. DeVita, Hellman, and Rosenberg’s cancer: principles & practice of oncology. 8ªed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 117-34. EVOLUCAO DAS PATOGENESIS E METASTASIS; PATOLOGIA CLINICA E CORRELACOES ANATOMICAS; HETEROGENEIDADE; METASTASIS; CELULAS METASTATICAS/RARIDADE; MODELOS ALTERNATIVOS; MODELO DE INTEGRACAO PARA METASTASES; HIPOXIA; RESISTENCIA/APOPTOSIS; ORIGEM DA CELULA; MORTALIDADE; PROGRESSAO METASTATICA/VIRULENCIA METASTATICA; EXTRAVASAMENTO E COLONIZACAO |
| 6/222 | US=82 / Câncer Pierce GB, Damjanov I. The pathology of cancer. In: McKinnell RG, Parchment RE, Perantoni AO, Damjanov I, Pierce B. The biological basis of cancer. 2ªed. New York: Cambridge University Press, 2006. p. 14-50. TUMORES MALIGNOS VERSUS BENIGNOS; DIAGNOSTICOS DE TUMORES MALIGNOS E BENIGNOS; CLASSIFICACAO; NOMENCLATURA; METASTASES; TUMORES MARCADORES; OBSTRUCAO GASTRINTESTINAL; CAQUEXIA; INFECCAO; REGRESSAO EXPONTANEA; DORMENCIA; LATENCIA; APOPTOSIS |
| 7/222 | US=82 / Câncer Perantoni AO. Cancer-associated genes. In: McKinnell RG, Parchment RE, Perantoni AO, Damjanov I, Pierce B. The biological basis of cancer. 2ªed. New York: Cambridge University Press, 2006. p. 145-94. ONCOGENE; FOTO ONCOGENES FUNCAO E SINAIS; REGULACAO DO CICLO CELULAR; APOPTOSIS; CONDUTAS GENETICAS; CLASSIFICACAO E PROTO-ONCOGENES/ONCOGENES; FATOR DE CRESCIMENTO E RECEPTORES; NAO-RECEPTORES TIROSINE QUINASES; SINAIS NUCLEARES; ATIVACAO TRANSCRICIONAL; REGULACAO DO DNA; SINTESES DO CICLO CELULAR; MECANISMOS E ATIVACAO DO ONCOGENE; CARCINOGENESES E ATIVACAO DO ONCOGENE; COOPERACAO/ONCOGENE; CELULAS NORMAIS SUPRESSORAS E CRESCIMENTO DO TUMOR; ANGIOGENESIS E DESENVOLVIMENTO DO TUMOR; GENES E TUMOR SUPRESSOR; GENE SUPRESSOR E P53; APOPTOSIS; ENVELHECIMENTO; BIOLOGIA MOLECULAR |
| 8/222 | US=90 / Câncer Booth C, Potten CS. The intestine as a model for studying stem-cell behavior. In: Teicher BA. Tumor models in cancer research. New Jersey: Humana press, 2002. p. 337-57. |
| 9/222 | US=90 / Câncer Stephens LC, Meyn RE. Apoptosis in vivo. In: Teicher BA. Tumor models in cancer research. New Jersey: Humana press, 2002. p. 633-45. PERSPECTIVA HISTORICA; RECONHECIMENTO E QUANTIFICACAO DE APOPTOSE; QUANTIFICACAO DE APOPTOSE IN VITRO; APOPTOSE E TUMOR BIOLOGICO; REGULACAO GENETICA E APOPTOSE; APOPTOSE E TERAPIA DO CANCER |
| 10/222 | US=12 / Dermatologia Bogenrieder T, Elder DE, Herlyn M. Molecular and cellular biology. In: Balch CM, Houghton NA, Sober AJ, Soong S. Cutaneous melanoma. 4ªed. St. Louis: Quality Medical Publishing, 2003. p. 713-51. SISTEMA PIGMENTAR HUMANO; REGULADORES CICLO CELULAR; ALTERACOES DO RETINOBLASTOMA PRIMARIO; P53 TUMOR SUPRESSOR E MELANOMA; APOPTOSIS; PROGRAMA DO APOPTOSE EM MELANOMA; INTERACAO CELULAR E ADESAO MOLECULAR; SINTESES E PERSPECTIVAS |
| 11/222 | US=24 / Pélvis Young GP, Rozen P, Levin B. How does colorectal cancer develop?. In: Rozen P, Young GP, Levin B, Spann SJ. Colorectal cancer in clinical practice: prevention, early detection and management. 2ª ed. New York: Taylor & Francis, 2006. p. 27-46. BIOLOGIA DO CANCER COLORETAL; APOPTOSIS; EVENTOS GENETICOS QUE OCORREM DURANTE A ONCOGENESIS; CARCINOGENESIS QUIMICO; METABOLISMO CARCINOGENESIS; INSTABILIDADE GENOMICA; INSTABILIDADE CROMOSSOMICA; INSTABILIDADE MICROSATELITE; IMPORTANCIA BIOLOGICA; EVENTOS GENETICOS; FATORES EPITELIAIS; FATORES SISTEMICOS; COMPONENTES DA DIETA ESPECIFICA; ONCOGENESIS; MICRONUTRIENTES; DIETA/PROTEINA |
| 12/222 | Câncer Moreira MP, Silva LM, Martins WK. The role of GADD45A in resistance to oxidative stress-mediated cell death in human colon tumor cell lines. Applied Cancer Research, São Paulo: Tecmedd, v.29, n.4, p. 179-84, 2009. ISSN 1980-5578. Disponível em: http://accamargo.phlnet.com.br/applied/ACR2009294p.179-84.pdf |
| 13/222 | US=98 / Biol/Mol Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. 376 p. ISBN 978-084939192-7. |
| 14/222 | US=56 / Biol/Mol Mor G, Alvero AB. Apoptosis and cancer: methods and protocols. New Jersey: Humana Press, 2008. 266 p. (Methods in Molecular Biology). ISBN 978-1-58829-457-9. |
| 15/222 | US=60 / Biol/Mol Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. 384 p. ISBN 978-1-4020-9596-2. APOPTOSE; NEOPLASIAS; PROCESSOS APOPTOTICOS; DOENCAS NEOPLASICAS |
| 16/222 | US=92 / Biol/Mol Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. 599 p. (Cancer Drug Discovery and Development). ISBN 978-1-58829-527-9. |
| 17/222 | US=2-A / Biol/Mol Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. v.2. 461 p. ISBN 978-3-527-31237-5. |
| 18/222 | US=2 / Biol/Mol Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. v.1. 668 p. ISBN 978-3-527-31237-5. |
| 19/222 | US=32 / Gastro Selzner M, Clavien PA. Induction of apoptosis in liver tumors. In: Clavien PA, Breitenstein S. Malignant liver tumors: current and emerging therapies. 3ª ed. New Jersey: John Wiley & Sons, 2010. p. 393-9. ISBN 978-1-4051-7976-8. |
| 20/222 | US=60 / Biol/Mol Karna P, Yang L. Apoptotic signaling pathway and resistance to apoptosis in breast cancer stem cells. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 1-23. ISBN 978-1-4020-9596-2. RESISTENCIA A APOPTOSE; CELULAS TRONCO EM NEOPLASIAS DE MAMA; TERAPIA DE ALVO MOLECULAR; VIA APOPTOTICA; MECANISMOS DE RESISTENCIA A APOPTOSE |
